SERPINB3 and head and neck squamous cell carcinoma: In this study, the sensitivity of SCC antigen for stage 0–II HNSCC cases was only 23.5%, and that of CYFRA 21‐1, another traditional tumor marker for HNSCC and potential early detection marker 40, was only 11.8%.